切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2018, Vol. 12 ›› Issue (02) : 103 -106. doi: 10.3877/cma.j.issn.1674-3946.2018.02.004

所属专题: 述评/论坛 总编推荐 文献

专家论坛

腹腔镜胃癌根治术联合脏器切除原则和疗效评价
刘健1, 刘彤1,()   
  1. 1. 300052 天津,天津医科大学总医院普通外科
  • 收稿日期:2017-05-25 出版日期:2018-02-26
  • 通信作者: 刘彤

Therapeutic principles and clinical outcome of laparoscopic combined organ resection in treating gastric cancer

Jian Liu1, Tong Liu1,()   

  1. 1. Department of General Surgery, General Hospital of Tianjin Medical University, Tianjin 300052, China
  • Received:2017-05-25 Published:2018-02-26
  • Corresponding author: Tong Liu
  • About author:
    Corresponding author: Liu Tong, Email:
引用本文:

刘健, 刘彤. 腹腔镜胃癌根治术联合脏器切除原则和疗效评价[J]. 中华普外科手术学杂志(电子版), 2018, 12(02): 103-106.

Jian Liu, Tong Liu. Therapeutic principles and clinical outcome of laparoscopic combined organ resection in treating gastric cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2018, 12(02): 103-106.

胃癌根治联合受累脏器切除可缓解一些局部晚期胃癌症状、改善生活质量、延长生存时间,甚至可以达到治愈。腹腔镜手术创伤小、出血少,术后恢复快,有经验的中心逐渐尝试胃癌根治联合被侵脏器切除术。常见的联合脏器切除包括联合脾脏切除、胆囊切除、胰体尾切除、胰十二指肠切除、肝切除和子宫双附件切除等。由于技术难度较大、学习曲线较长,开展的中心和病例数较少,其安全性、可行性和远期效果缺乏高级别的证据支持,需多中心的临床研究去验证。

Radical gastrectomy combined with combined organ resection could relieve symptoms, improve quality of life, prolong survival and even cure some locally advanced gastric cancer. Laparoscopic surgery has the advantages, such as minimal trauma, less bleeding and faster postoperative recovery. The experienced center has gradually attempted to apply to combined organ resection for gastric cancer, including combined with splenectomy, pancreatic body and tail, pancreaticoduodenectomy, cholecystectomy, liver resection, hysterectomy and bilateral oophorectomy. Due to technical difficulties, the long learning curve, less number of cases in current studies and the lack of control group, the safety, feasibility and long-term effect of laparoscopic combined combined organ resection for gastric cancer still require high level evidences, therefore more multicenter clinical trials should be performed deeply.

[1]
Lindsey AT, Freddie B, Rebecca LS, et al. Global cancer statistics,2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
[2]
何裕隆.腹腔镜下胃癌根治联合结肠部分切除的实践与评价[J/CD].中华普外科手术学杂志(电子版),2017,11(6):461-463.
[3]
Kobayashi A, Nakagohri T, Konishi M, et al. Aggressive Surgical treatment for T4 gastric cancer[J]. J Gastrointest Surg, 2004, 8(4):464-470.
[4]
Hu Y, Huang C, Sun Y, et al. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial[J]. J Clin Oncol, 2016, 34(12):1350-1357.
[5]
王大广,张洋,孙璇,等. 腹腔镜全胃联合胰体尾和脾切除术[J]. 中华消化外科杂志,2012, 11(2):132-135.
[6]
Lee CM, Rao J, Son SY, et al. Laparoscopic gastrectomy for gastric cancer with simultaneous organ resection[J]. J Laparoendosc Adv Surg Tech, 2013, 23(10):861-865.
[7]
Okajima K, Isozaki H. Splenectomy for treatment of gastric cancer: Japanese experience[J]. World J Surg, 1995, 19(4):537-540.
[8]
Sano T, Sasako M, Mizusawa J, et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma[J]. Ann Surg, 2017, 265(2):277-283.
[9]
李国新,牟廷裕,余江,等. 胰后入路保留胰脾的原位脾门淋巴结清扫在腹腔镜胃癌根治术中的应用[J].中华消化外科杂志,2012, 11(1):58-60.
[10]
Wang W, Liu Z, Xiong W, et al. Totally laparoscopic spleen-preserving splenic hilum lymph nodes dissection in radical total gastrectomy: an omnibearing method[J]. Surg Endosc, 2016, 30(5):2030-2035.
[11]
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4)[J]. Gastric Cancer,2017, 20(1):1-19.
[12]
Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial[J].Lancet, 1996, 347(9007):995-999.
[13]
Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer[J]. Br J Surg, 2006, 93(5):559-563.
[14]
Wang JY, Huang TJ, Chen FM, et al. A comparative study of pancreatectomy and pancreas-preserving gastrectomy in advanced gastric carcinomas[J].Hepatogastroenterology, 2004, 51(58):1229-1232.
[15]
Croome KP, Farnell MB, Que FG,et al. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches[J]? Ann Surg, 2014, 260(4):633-638.
[16]
Yoshimura F, Shinohara T, Kawamura Y, et al.Laparoscopic Pancreaticoduodenectomy for Locally Advanced Gastric Cancer[J]. Jpn J Gastroenterol Surg, 2011, 44(6):787-794.
[17]
Kimura J, Kunisaki C, Takagawa R, et al. Is RoutineProphylactic Cholecystectomy Necessary During Gastrectomy for Gastric Cancer[J]? World J Surg, 2017, 41(4):1047-1053.
[18]
Murata A, Okamoto K, Muramatsu K, et a1. Effects of additional laparoscopic cholecystectomy on outcomes of laparoscopic gastrectomy in patients with gastric cancer based on a national administrativedatabase[J]. J Surg Res, 2014, 186(1):157-163.
[19]
Jeong IH, Choi SU, Lee SR, et a1. Outcomes after combined laparoscopic gastrectomy and laparoscopic cholecystectomy in gastric cancer patients[J].Eur Surg Res, 2009, 42(4):203-208.
[20]
de Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrencefollowing curative intent surgery for colorectal liver metastasis: an international multi- institutional analysis of 1669 patients[J]. Ann Surg, 2009, 250(3):440-448.
[21]
Petrelli F, Coinu A, Cabiddu M, et al. Hepatic resection for gastric cancer liver metastases: A systematic review and meta-analysis[J].J Surg Oncol, 2015, 111(8):1021-1027.
[22]
Li J, Xi H, Cui J, et al. Minimally invasive surgery as a treatment option for gastric cancer with liver metastasis: a comparison with open surgery[J]. Surg Endosc,2018, 32(3):1422-1433.
[23]
Jiang R, Tang J, Cheng X, et al. Surgical treatment for patients with different origins of Krukenberg tumors: Outcomes and prognostic factors[J]. European Journal of Surgical Oncology (EJSO), 2009, 35(1):92-97.
[1] 黄来明, 张旭东. 雾化吸入布地奈德混悬液联合气管导管涂抹达克罗宁胶浆对改善妇科腹腔镜手术气管插管全身麻醉患者咽喉部不适作用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 480-486.
[2] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[3] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[4] 闫笑生, 郑智, 翟育豪, 张海翘, 王鈢, 刘小野, 尹杰, 张军. Borrmann Ⅳ型胃癌临床诊断、病理特征及预后分析[J]. 中华普通外科学文献(电子版), 2023, 17(05): 346-351.
[5] 王龙彪, 刘洪, 董天雄. 中心体扩增细胞占比和C反应蛋白-白蛋白比值对胃癌根治术治疗预后的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 352-356.
[6] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[7] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[8] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[9] 王鸿彬, 何晓, 吴菁宙. 腹腔镜近端胃切除术中背驮式间置空肠单通道重建术在AEG手术的安全性及抗反流效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 526-529.
[10] 宋钰, 赵阳, 王惠君, 廖新华. 术前BMI与可切除胃癌患者术后远期生存的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 530-533.
[11] 高静, 严学倩, 及月茹, 郝淼旺, 刘苍春. 胃癌患者以慢性贫血为首发表现的高危因素Logistic分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 534-537.
[12] 李晓晖, 上官昌盛, 向英, 裴芝皆, 车俊志, 谢飞. 3D腹腔镜袖状胃切除术后机体能量代谢与多囊卵巢综合征患者性激素水平关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 538-541.
[13] 张彬, 贾贵清, 吴东松, 曹绿洲, 张焰凌, 黄灏, 赵高平. 早期胃癌保功能手术治疗13例病例分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 575-579.
[14] 徐瑜杰, 赵国栋. 晚期胃癌治疗方法的研究进展和挑战[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 451-455.
[15] 牛朝, 李波, 张万福, 靳文帝, 王春晓, 李晓刚. 腹腔镜袖状胃切除联合胆囊切除治疗肥胖合并胆囊结石安全性和疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 635-639.
阅读次数
全文


摘要